We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIST icon
1401
Vista Energy
VIST
$7.32B
– –
-8,000
Closed -$382K
VITL icon
1402
Vital Farms
VITL
$525M
– –
-11,451
Closed -$441K
VLY icon
1403
Valley National Bancorp
VLY
$8.04B
– –
-16,460
Closed -$147K
VMC icon
1404
Vulcan Materials
VMC
$36.9B
– –
-1,066
Closed -$278K
VRDN icon
1405
Viridian Therapeutics
VRDN
$2.67B
– –
-17,401
Closed -$243K
VSTM icon
1406
Verastem
VSTM
$610M
– –
-180,400
Closed -$749K
VTI icon
1407
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
– –
-12,700
Closed -$3.86M
YARW
1408
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
– –
-1,292
Closed -$107K
W icon
1409
Wayfair
W
$14.6B
– –
-9,828
Closed -$503K
WAB icon
1410
Wabtec
WAB
$49.3B
– –
-1,554
Closed -$325K
WBA
1411
DELISTED
Walgreens Boots Alliance
WBA
– –
-133,210
Closed -$1.53M
WING icon
1412
Wingstop
WING
$3.18B
– –
-3,567
Closed -$1.2M
WM icon
1413
Waste Management
WM
$91B
– –
-896
Closed -$205K
WOLF icon
1414
Wolfspeed
WOLF
$1.71B
– –
-300,000
Closed -$120K
WRBY icon
1415
Warby Parker
WRBY
$3.27B
– –
-11,546
Closed -$253K
WTRG icon
1416
Essential Utilities
WTRG
$11.4B
– –
-21,690
Closed -$806K
XBI icon
1417
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-15,000
Closed -$1.24M
XLF icon
1418
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
– –
-10,040
Closed -$526K
XLK icon
1419
State Street Technology Select Sector SPDR ETF
XLK
$123B
– –
-1,620
Closed -$205K
XLP icon
1420
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
– –
-925
Closed -$222K
XRAY icon
1421
Dentsply Sirona
XRAY
$2.43B
– –
-13,538
Closed -$215K
Z icon
1422
Zillow
Z
$7.56B
– –
-13,078
Closed -$916K
ZROZ icon
1423
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.32B
– –
-3,610
Closed -$242K
FLUT icon
1424
Flutter Entertainment
FLUT
$16.4B
– –
-5,531
Closed -$1.58M
CTNM
1425
Contineum Therapeutics
CTNM
$566M
– –
-13,920
Closed -$55.3K
54 55 56
57
58

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.